Success Stories: A Research Fellow in the Field of Biomedical Sciences Secures NIW Approval with our Constant Help. Thanks to Premium Processing, She even Secured EB1-A Approval in less than 3 months only.


Client’s Testimonial:

“Thank You for the message. I am grateful for your efforts to make it happen.”

On March 23rd, 2023 and April 17th, 2023, we received another EB-2 NIW (National Interest Waiver) approval and EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Research Fellow

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 23rd, 2023 (NIW) and April 17th, 2023 (EB1A)

Processing Time: 3 months, 21 days (NIW) and 2 months, 22 days (EB1A) (Premium Processing Requested)

Case Summary:

An EB-2 NIW (National Interest Waiver) petition approval was granted to a research fellow with a Ph.D. in applied biology from India. Before starting with a client-attorney agreement, the North American Immigration Law Group judged her provided credentials to determine her NIW’s success. We asserted that we could lead her to obtain the national interest waiver after a thorough evaluation only.

Our team thus, followed a proficient process of analyzing her background, paperwork, and the associated evidence, and were then only confident that they were enough to persuade USCIS and get our client the NIW approval.

Since, the method of obtaining a green card involves two steps, that is, filing an I-140 petition and an I-485 application, our client even retained us for another I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category as well.

We highlighted the following aspects to make her case a success:

  • The 13 peer-reviewed scientific articles she published in some of the most discerning, high-impact journals in the field of biomedical sciences.
  • A splendid record of obtaining 383 citations in other peer-reviewed journal articles.
  • Cited by researchers in at least 37 countries.
  • Also been invited to review and evaluate the work of her peers no fewer than 11 times, serving as major evidence of her supremacy in the field.

Moreover, our client’s work is optimizing therapeutic strategies for acute myeloid leukemia by elucidating the molecular mechanisms underpinning this disease. Specifically, She identified leukemia stem cell markers associated with acute myeloid leukemia and determined that the critical transcription factor is an ideal molecular target for therapy-resistant quiescent stem cells in acute myeloid leukemia. These novel findings are facilitating the development of advanced treatment strategies for blood cancer, thereby mitigating the burden of this disease and related disorders.

Our client’s study has even received funding from the Department of Biotechnology-the Government of India, the Indian Council of Medical Research, and the German Research Foundation. This funding serves as clear evidence of the merit of her work in glucose-dependent insulin secretion and its widespread implications for treating diabetes.

Furthermore, considering the impactful articles our client has published, the numerous citations her work has attained, and the funding it has been granted, has proven her to be a prominent and influential member of the field, having provided many important and influential contributions that are addressing the needs of both the academic and greater community.

Also, the following statement is excerpted from one of the four recommendation letters submitted:

“[Client’s] work is essential to earn the United States a place at the forefront of diagnostic methods targeting debilitating childhood leukemia…[Client] has previously investigated molecular markers of JMML to identify poor and favorable prognostic sample subsets. She found that DNA methylation is an optimal marker to predict patients’ overall survival and the probability of relapse. [Client’s] novel prognosis method is relevant to improving JMML patient outcomes in the United States, and it provides an opportunity for the nation to take the lead in diagnosing this childhood disease.”

All of this evidence is fully supported and corroborated by letters from internationally recognized experts in the field who have used our client’s work in their research endeavors and attest to its influence and major significance. The totality of this evidence shows that our client is one of that small percentage who has risen to the very top of her field and has sustained both national and international acclaim.

She is therefore fully qualified as an individual of extraordinary ability in her field of expertise.

We are thrilled that our team was once again successful in persuading USCIS of the importance of our client’s research in the United States. Thus, she was granted not only EB1-A approval in less than 3 months only (thanks to Premium Processing) but also NIW. We would sincerely like to wish her success in her future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.